People · Operator
Named in public records as an officer, director or promoter · active 2016–2018 · Biotech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CHD Bioscience, Inc. | — | Biotech | Series A | $18.7M | $3.3M | 2016 |
Stephen Coder at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stephen Coder on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Alan Smith | 1 | 4 |
| Michael Handley | 1 | 4 |
| William Nelson | 1 | 3 |
| Roy Carver, Jr. | 1 | 2 |
| Dennis Templar | 1 | 2 |
| Douglas Coder | 1 | 2 |
| Theodore Ziemann | 1 | 2 |
| Michael Litwack | 1 | 2 |
| Cathy Sohn | 1 | 1 |
| Steve Coder | 1 | 1 |
| Michael Voss | 1 | 1 |
| William Nelson, MD, Ph.D. | 1 | 1 |
| Alan Smith, Ph.D. | 1 | 1 |
| Christopher Rudd | 1 | 1 |
| Ed Neas, Ph.D. | 1 | 1 |
| Christopher Ruud | 1 | 1 |
| Doug Coder | 1 | 1 |
| Ted Ziemann | 1 | 1 |
| Loretta Mealy | 1 | 1 |
| Alan Ruud | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.